Tag #Cvs Health

Showing 1 to 2 of 2 results

theglobeandmail.com
🌐 85% Global Worthiness
News related image

Eli Lilly Q1 Earnings Beat Expectations Despite Zepbound Reimbursement Setback

Eli Lilly exceeded Q1 2024 earnings expectations with \$12.73 billion in revenue and \$3.34 adjusted EPS, but CVS's removal of Zepbound from its formulary, starting July 1, caused a 5 percent stock drop due to price competition with Novo Nordisk's Wegovy; Lilly holds a 53.3 percent U.S. market share...

Progress

36% Bias Score

Good Health and Well-being
forbes.com
🌐 75% Global Worthiness
News related image

Walgreens Considers Breakup, Bucking Healthcare Consolidation Trend

Walgreens Boots Alliance is considering splitting into three companies: Boots UK, U.S. retail pharmacies, and a specialty pharmacy, diverging from the healthcare consolidation trend exemplified by CVS Health's integrated model. This follows Walgreens' financial losses and struggles with its VillageM...

Progress

48% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results